ICBEA 2022 - 6th International Conference on Biomedical Engineering and Applications (ICBEA 2022)

Website http://www.icbea.org/ | Edit Freely

Category Biomedical Engineering and Applications

Deadline: March 25, 2022 | Date: May 13, 2022-May 15, 2022

Venue/Country: Hangzhou, China

Updated: 2022-02-22 13:05:36 (GMT+9)

Call For Papers - CFP

Abbreviation: ICBEA 2022

2022 6th International Conference on Biomedical Engineering and Applications (ICBEA 2022) will be held during May 13-15, 2022 in Hangzhou, China.

Conference Website: http://www.icbea.org/

Paper Publication

International Conference Proceedings by ACM (ISBN:978-1-4503-9647-9), which will be archived in ACM Digital Library and indexed by Ei Compendex and Scopus.

Keynote Speakers

Prof. Mohamad Sawan (FIEEE, FCAE, FEIC), Westlake University;

Prof. Peter W. Macfarlane, The University of Glasgow, UK;

Dr. Nan Wu, Peking Union Medical College, China

Invited Speakers

Prof. Yungang Xu, Xi’an Jiaotong University, China;

Prof. Lei Li, Shenzhen Bay Laboratory, China;

Dr. Dongyu Zhao, Peking University, China;

Asst. Prof. Hangjin Jiang, Zhejiang University, China;

Dr. Xin Sheng, Zhejiang University Medical Center, China;

Dr. Xiaogen Zhou, University of Michigan, USA

Conference Venue

Zhejiang University, Hangzhou, China

Adderss: Zijingang Campus of Zhejiang University, No. 866 yuhangtang Road, Sandun Town, Xihu District, Hangzhou

Website: http://zdzsc.zju.edu.cn

Submission and Contact Method

Electronic Submission System: http://confsys.iconf.org/submission/icbea2022

E-mail: icbeacbees.net

Tel.: +852-3500-0799 (English)/+86-28-86528465 (Chinese)

WeChat ID for consultation: CBEES-BBS

Conference Secretary: Ms. Phoebe Wang

ICBEA 2022 provides a platform for researchers, engineers, academicians as well as industrial professionals from all over the world to present their research results and development activities on Biomedical Engineering and Applications. Please visit the conference website: http://www.icbea.org/ for more conference information.